Published: July 25, 2023
Laboratory Diagnosis of Streptococcus pyogenes
Diseases caused by the bacterium Streptococcus pyogenes (Group A β-hemolytic Streptococcus) constitute one of the major health problems worldwide, with human skin and mucous membranes being the only known reservoir.
Streptococcus pyogenes is associated with a wide variety of infections ranging in severity. Some people may be colonized without showing any symptoms or signs of the disease. The vast majority of infections caused by this bacterium are mild and short-lived; it is the most common cause of bacterial pharyngitis in children and adolescents, with peaks in incidence during the winter and early spring.
Group A Streptococcus pharyngitis is characterized by the sudden onset of a sore throat, fever, headaches, abdominal pain, nausea, and vomiting. The oropharynx is hyperemic, with or without tonsillar exudate, and there is tender anterior cervical lymphadenopathy. Another, less common manifestation is scarlet fever.
Most cases of Streptococcus pyogenes infections occur without complications; however, in a small percentage of cases, they may present with a more severe clinical course, including bacteremia, pneumonia, toxic shock syndrome, or lead to immunological complications (following an acute infection) such as acute rheumatic fever and acute glomerulonephritis, with chronic kidney disease as a possible sequela.
In severe cases, Streptococcus pyogenes infections can be fatal, particularly in invasive disease (e.g., necrotizing fasciitis) or as a consequence of rheumatic heart disease, a sequela of acute rheumatic fever.
Transmission occurs from person to person via respiratory droplets—spread through talking or coughing—or through direct skin contact. Cases of food poisoning have been reported.
Streptococcus pyogenes is the most common cause of acute bacterial pharyngitis in children. A rapid diagnosis allows for the initiation of appropriate antibiotic therapy, which provides symptom relief, reduces complications and sequelae, and decreases transmission.
Laboratory confirmation of the diagnosis of acute pharyngitis caused by Group A Streptococcus is recommended in children.
Laboratory Diagnosis
1. Rapid antigenic diagnostic test (RADT)
This test involves the direct detection of the Group A Streptococcus-specific antigen from oropharyngeal swab samples collected by experienced healthcare professionals.
This test provides rapid results, allowing for the initiation of appropriate treatment; however, culture remains the recommended gold standard.
A negative RAGT result must be confirmed by oropharyngeal culture in children and adolescents with signs and symptoms strongly suggestive of Group A Streptococcus infection.
A positive result on the TDAR does not require confirmation by culture. A positive result is considered a diagnosis of acute pharyngitis caused by Group A Streptococcus.
2. Microbiological Culture
Oropharyngeal swab culture remains the gold standard for the diagnosis of acute pharyngitis caused by Streptococcus pyogenes.
A properly collected sample has a sensitivity of 90–95% and a specificity of 99%.
Culture is the only test that allows for antibiotic susceptibility testing, which enables monitoring of the evolution of antimicrobial resistance.
Streptococcus pyogenes remains susceptible to penicillin.
In cases of hypersensitivity to β-lactams, the culture should be performed in a way that allows for the assessment of resistance to macrolides and clindamycin.
The main limitation of culture is the turnaround time (at least 24 to 48 hours).
3. Molecular Tests
Molecular tests (nucleic acid amplification tests or PCR—Polymerase Chain Reaction tests) have been increasingly used in routine practice to detect Streptococcus pyogenes in oropharyngeal samples.
They can be used as a primary diagnostic test for acute infection or if the rapid antigen test is negative.
The main limitations are the complexity of this type of method and the associated cost.
4. Serological Tests
In the diagnosis of Streptococcus infection, serological tests are indicated for diagnosing post-streptococcal disease, as well as for monitoring the progression of acute rheumatic fever and glomerulonephritis.
Antistreptococcal antibody titers rise 7 to 14 days after the onset of infection and reach a serum peak at 3 to 6 weeks. They may remain elevated for months.
These tests are not indicated for the acute diagnosis of pharyngitis.
A 4-fold increase in antibody titer is considered diagnostic of a previous streptococcal infection.
Antibody levels can be influenced by several factors: the site of infection, the time elapsed since the onset of infection, a history of Streptococcus infection, age, and antibiotic therapy.
The most widely used serological tests are anti-streptolysin O (anti-ASO) and anti-DNase B (anti-deoxyribonuclease B).
Anti-ASO antibodies peak between 3 and 6 weeks after infection and are higher following an upper respiratory tract infection than in skin infections, where the elevation of these antibodies is not as pronounced.
Elevated anti-ASO serological levels are not specific to Streptococcus pyogenes.
Anti-DNase B titers remain elevated for a longer period than anti-ASO titers and are more indicative of past skin infections.
In the diagnosis of rheumatic fever, both serological tests should be ordered, since anti-ASO titers are elevated in only 80 to 85% of cases.
If you have any questions, please contact us.
We'll be happy to help.
CLINICAL PATHOLOGY LABORATORY
